Financial Life Planners Makes New $133,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Financial Life Planners bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 264 shares of the healthcare conglomerate’s stock, valued at approximately $133,000.

A number of other hedge funds also recently bought and sold shares of UNH. Jennison Associates LLC raised its stake in UnitedHealth Group by 1.5% in the 4th quarter. Jennison Associates LLC now owns 244,477 shares of the healthcare conglomerate’s stock valued at $123,671,000 after purchasing an additional 3,694 shares during the last quarter. One Wealth Advisors LLC grew its stake in UnitedHealth Group by 3.9% during the 4th quarter. One Wealth Advisors LLC now owns 3,706 shares of the healthcare conglomerate’s stock valued at $1,875,000 after acquiring an additional 138 shares in the last quarter. Muirfield Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 68.6% during the 4th quarter. Muirfield Wealth Advisors LLC now owns 737 shares of the healthcare conglomerate’s stock worth $373,000 after purchasing an additional 300 shares during the last quarter. Rice Partnership LLC boosted its stake in UnitedHealth Group by 3.3% during the fourth quarter. Rice Partnership LLC now owns 6,389 shares of the healthcare conglomerate’s stock worth $3,232,000 after buying an additional 204 shares during the last quarter. Finally, Resonant Capital Advisors LLC raised its holdings in shares of UnitedHealth Group by 1.7% during the 4th quarter. Resonant Capital Advisors LLC now owns 2,630 shares of the healthcare conglomerate’s stock worth $1,330,000 after acquiring an additional 43 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. 0.33% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts have issued reports on UNH shares. Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. UBS Group reduced their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, Oppenheimer raised their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Down 0.6 %

Shares of UnitedHealth Group stock opened at $542.30 on Monday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market cap of $499.07 billion, a price-to-earnings ratio of 34.99, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company’s 50-day simple moving average is $536.17 and its 200-day simple moving average is $565.20.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the company posted $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.